Autolus Therapeutics PLC (AUTL)
3.08
+0.07
(+2.33%)
USD |
NASDAQ |
Nov 15, 16:00
3.08
0.00 (0.00%)
After-Hours: 20:00
Autolus Therapeutics Revenue (Annual): 1.698M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.698M |
| December 31, 2022 | 6.194M |
| December 31, 2021 | 1.507M |
| December 31, 2020 | 0.242M |
| December 31, 2019 | 2.908M |
| Date | Value |
|---|---|
| December 31, 2018 | |
| September 30, 2018 | |
| September 30, 2017 | 1.693M |
| September 30, 2016 | 1.212M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
0.242M
Minimum
2020
6.194M
Maximum
2022
2.510M
Average
1.698M
Median
2023
Revenue (Annual) Benchmarks
| Adaptimmune Therapeutics PLC | 60.28M |
| Biodexa Pharmaceuticals PLC | 0.4741M |
| NuCana PLC | -- |
| TC BioPharm (Holdings) PLC | -- |
| Bicycle Therapeutics PLC | 26.98M |